首頁 > 市場調查報告書 > 醫療設備

醫學影像診斷分子呈像/呈影劑

市場調查報告書

商品編碼

1918126

近紅外線成像市場－2026-2031年預測

Near Infrared Imaging Market - Forecast from 2026 to 2031

出版日期: 2026年01月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 149 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

近紅外線成像市場預計將從 2025 年的 1,446,540,000 美元成長到 2031 年的 2,910,381,000 美元，複合年成長率為 12.36%。

受技術進步、臨床應用拓展和疾病負擔加重的推動，近紅外線成像市場正經歷快速成長。這項利用近紅外線產生精細影像的非破壞性成像技術，憑藉其獨特的功能和良好的患者安全性，在多個醫學領域中獲得了廣泛應用。慢性疾病（尤其是癌症）盛行率的上升，以及螢光劑研發的持續推進，正在推動市場擴張。

主要市場促進因素

技術優勢

近紅外線成像技術具有諸多優勢，這些都是其關鍵的成長要素。該技術是一種非電離成像方法，消除了輻射暴露的擔憂，與X光和電腦斷層掃描等其他技術相比，顯著提高了患者安全性。這種安全性使得在臨床需要時可以重複成像，而不會產生累積輻射風險。

這項技術能夠實現疾病的早期檢測，尤其適用於癌症等疾病，從而實現及時干預並改善患者預後。近紅外線影像的非侵入性特性可減輕病患不適，降低併發症風險，並有助於提高病患對監測通訊協定的遵從性。這些綜合優勢使得近紅外線成像技術對尋求更安全、更人性化的診斷和監測解決方案的臨床醫生越來越具有吸引力。

慢性病盛行率

慢性疾病（包括癌症、心血管疾病和神經系統疾病）的日益增多，顯著推動了對近紅外線成像等先進成像技術的需求，以輔助疾病的高階管理和治療方案的發展。慢性疾病負擔沉重，2020年美國有8,100萬人患有多種慢性疾病，顯示其盛行率很高。在印度，超過50%的死亡是由慢性疾病造成的，目前有7,700萬印度人患有糖尿病。預計到2045年，這一數字將增加至1.34億。這些數據凸顯了不斷擴大的患者群體對近紅外線成像所能提供的先進診斷和監測能力的需求。

腫瘤學應用

近紅外線成像技術在腫瘤學領域得到了廣泛應用，包括腫瘤定位、手術導航和療效監測。螢光劑能夠靶向特定癌細胞，在手術過程中提供即時回饋，並輔助實現腫瘤的徹底切除。全球癌症負擔的日益加重進一步提升了對這項技術的需求。癌症是全球首要死因，2020年約有1,000萬人死於癌症。此外，每年約有40萬名兒童罹患癌症。這些數據表明，我們迫切需要先進的成像技術來提高手術精度和治療效果。

微創手術和遠端成像

近紅外線成像技術具有非侵入性和便攜的特點，使其成為即時診斷和遠端成像應用的理想選擇，這與醫學領域向微創方法轉變的趨勢相契合。 2020年，在1,560萬例美容手術中，有1,320萬例採用微創手術，這充分體現了微創手術的普及程度。疫情期間，約95%的美國醫療機構提供遠端醫療服務，凸顯了醫療系統遠距會診的能力。由市場領導者開發的攜帶式成像設備進一步提高了遠端成像解決方案的可近性，並拓展了該技術的潛在應用範圍。

市場機遇

慢性病日益普遍和人口老化為市場參與者提供了改進技術和提升患者體驗的機會。新型近紅外線螢光劑的研發和核准為標靶成像和診斷開闢了新的途徑，拓展了該技術的臨床效用和市場潛力。

市場限制

儘管近紅外線成像市場成長前景強勁，但仍面臨技術和營運方面的挑戰。與超音波和磁振造影等其他成像方式相比，近紅外線光在生物組織中的穿透深度有限。這項限制制約了深層解剖結構的影像，尤其是在組織增厚或體重指數（BMI）較高的患者中。

此外，近紅外線成像缺乏標準化的通訊協定和成像流程，可能會阻礙其與現有醫療實踐和成像工作流程的無縫銜接。隨著市場日趨成熟，建立廣泛認可的標準仍然是其發展面臨的關鍵挑戰。

區域趨勢與發展

由於癌症病例不斷增加、醫療保健支出不斷成長、政府支持以及對技術創新的早期應用，預計北美在預測期內將佔據顯著的市場佔有率。 2020年，美國報告了1,603,844例新增癌症病例，並記錄了602,347例癌症相關死亡病例。 Infiniti Electro-Optics、OmniVision和Karl Storz等主要市場市場領導的存在，正在推動區域市場的進一步發展。

近期發展凸顯了技術的持續創新。 2022年8月，島津公司開發了LuminousQuester NI系統，將高度靈活的相機硬體與使用者友善的軟體結合，助力藥物研發的進步。 2022年3月，Swift Medical公司推出了Swift Ray 1，這高光譜影像設備，能夠提供全面的臨床數據，用於監測和治療皮膚及傷口狀況。

本報告的主要優勢：

深入分析：取得以客戶群、政府政策和社會經濟因素、消費者偏好、垂直產業和其他細分市場為重點的深入市場洞察，涵蓋主要地區和新興地區。
競爭格局：了解主要企業採取的策略舉措，並了解透過正確的策略實現市場滲透的潛力。
市場促進因素與未來趨勢：探索動態因素和關鍵市場趨勢，以及它們將如何塑造未來的市場發展。
可執行的建議：利用洞察力為策略決策提供訊息，從而在動態環境中開拓新的業務管道和收入來源。
受眾範圍廣：對新興企業、研究機構、顧問公司、中小企業和大型企業都有益處且經濟高效。

它是用來做什麼的？

產業與市場洞察、商業機會評估、產品需求預測、打入市場策略、地理擴張、資本投資決策、法律規範及其影響、新產品開發、競爭影響

分析範圍

歷史資料（2021-2025 年）和預測資料（2026-2031 年）
成長機會、挑戰、供應鏈前景、法規結構、客戶行為和趨勢分析
競爭對手定位、策略和市場佔有率分析
按業務板塊和地區（國家）分類的收入成長和預測分析
公司概況（策略、產品、財務資訊、關鍵趨勢等）

The near infrared imaging market is experiencing rapid growth driven by technological advantages, expanding clinical applications, and increasing disease burden. This non-destructive imaging technology, which creates detailed images using near-infrared wavelengths, is gaining prominence across multiple medical specialties due to its unique capabilities and patient safety profile. The convergence of rising chronic disease prevalence, particularly cancer, alongside ongoing research and development in fluorescent agents, is propelling market expansion.

Primary Market Drivers

Intrinsic Technological Benefits

Near infrared imaging offers numerous advantages that constitute a significant growth driver. The technology provides a non-ionizing imaging modality that substantially enhances patient safety compared to alternative techniques such as X-ray or CT scans, eliminating radiation exposure concerns. This safety profile enables repeated imaging as clinically necessary without cumulative radiation risks.

The technology facilitates early disease detection, particularly for conditions like cancer, enabling timely intervention and improved patient outcomes. The non-invasive nature of near infrared imaging reduces patient discomfort, lowers complication risks, and supports better patient compliance with monitoring protocols. These combined advantages make NIR imaging increasingly attractive for clinicians seeking safer, more patient-friendly diagnostic and monitoring solutions.

Chronic Disease Prevalence

The increasing prevalence of chronic diseases-including cancer, cardiovascular conditions, and neurological disorders-has driven substantial demand for advanced imaging technologies like near infrared imaging to support enhanced disease management and treatment planning. The chronic disease burden is considerable: 81 million Americans had multiple chronic ailments in 2020, demonstrating high prevalence. In India, chronic diseases account for more than 50% of all deaths, while diabetes affects 77 million Indians currently, with projections indicating growth to 134 million by 2045. These statistics underscore the expanding patient populations requiring advanced diagnostic and monitoring capabilities that NIR imaging can provide.

Oncology Applications

Near infrared imaging technology has found extensive applications in oncology, including tumor localization, surgical guidance, and treatment response monitoring. NIR fluorescent agents can target specific cancer cells, providing real-time intraoperative feedback and aiding complete tumor removal. The expanding cancer burden globally amplifies demand for these capabilities: cancer represents the leading cause of death worldwide, accounting for almost 10 million deaths in 2020, while approximately 400,000 children develop cancer annually. These figures highlight the critical need for advanced imaging technologies that improve surgical precision and treatment outcomes.

Minimally Invasive Surgery and Remote Imaging

Near infrared imaging's non-invasive nature and portability make it well-suited for point-of-care and remote imaging applications, aligning with healthcare's broader shift toward minimally invasive approaches. In 2020, 13.2 million minimally invasive cosmetic procedures were conducted out of 15.6 million total cosmetic procedures, demonstrating the scale of minimally invasive surgical adoption. During the pandemic, approximately 95% of U.S. healthcare centers offered telehealth services, highlighting the healthcare system's capacity for remote care delivery. Market leaders' development of portable imaging devices further enhances accessibility for remote imaging solutions, expanding the technology's potential applications.

Market Opportunities

The growing chronic disease prevalence combined with rising elderly populations provides opportunities for market players to enhance technology and patient experience. Development and approval of novel NIR fluorescent agents creates new opportunities for targeted imaging and diagnostics, expanding the technology's clinical utility and market potential.

Market Constraints

Despite robust growth prospects, the near infrared imaging market faces technical and operational challenges. Near-infrared light demonstrates limited penetration depth in biological tissues compared to alternative modalities like ultrasound or MRI. This limitation restricts visualization of deeper anatomical structures, particularly in patients with increased tissue thickness or elevated body mass index.

Additionally, the absence of standardized protocols and imaging procedures for NIR imaging can hinder seamless integration into existing healthcare practices and imaging workflows. Establishing widely accepted standards remains an important developmental priority for market maturation.

Regional Dynamics and Developments

North America is positioned to hold significant market share during the forecast period, supported by rising cancer cases, increased healthcare expenditure, government support, and early adoption of technological advancements. In 2020, 1,603,844 new cancer cases were reported in the United States, with 602,347 cancer-related deaths recorded. The presence of major market leaders including Infiniti Electro-Optics, OmniVision, and Karl Storz further accelerates regional market development.

Recent developments underscore ongoing innovation. In August 2022, Shimadzu developed the LuminousQuester NI system combining adaptable camera hardware with user-friendly software to advance drug discovery research. In March 2022, Swift Medical launched Swift Ray 1, a hyperspectral imaging device that wirelessly attaches to smartphones, providing comprehensive clinical data for skin and wound condition monitoring and treatment.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2021 to 2025 & forecast data from 2026 to 2031
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information), and Key Developments among others.

Near Infrared Imaging Market Segmentation

By Product
Near Infrared Flourescence Imaging Systems
Near Infrared Flourescence & Bioluminescence Imaging Systems
By Application
Pre-Medical Imaging
Medical Imaging
Clinical Imaging
By End-User
Hospitals & Clinics
Research Laboratories
Others
By Geography
North America
United States
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
India
Japan
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. NEAR INFRARED IMAGING MARKET BY PRODUCT

5.1. Introduction
5.2. Near Infrared Flourescence Imaging Systems
5.3. Near Infrared Flourescence & Bioluminescence Imaging Systems

6. NEAR INFRARED IMAGING MARKET BY APPLICATION

6.1. Introduction
6.2. Pre-Medical Imaging
6.3. Medical Imaging
6.4. Clinical Imaging

7. NEAR INFRARED IMAGING MARKET BY END-USER

7.1. Introduction
7.2. Hospitals & Clinics
7.3. Research Laboratories
7.4. Others

8. NEAR INFRARED IMAGING MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others